Similar Papers

Paper Title
Journal
Date
Author
Comparison of pathological features and prognosis between orbital and systemic diffuse large B cell lymphoma
...
Chinese Journal of Experimental Ophthalmology | VOL. 32
, et. al. ...
10 Oct 2014
Multiply Relapsed Secondary CNS Non-Germinal Center Diffuse Large B-Cell Lymphoma Successfully Treated with CNS-Centric Therapy.
Lyndsey L Fournier ... Han W Tun
Journal of blood medicine | VOL. 14
Lyndsey L Fournier, et. al.Lyndsey L Fournier ... Han W Tun
01 Aug 2023
30. Genome-Wide Micro-RNA profiling distinguishes diffuse large B-Cell lymphoma of the central nervous system from systemic DLBCL
Connull Leslie ... Benhur Amanuel
Pathology | VOL. 46
Connull Leslie, et. al.Connull Leslie ... Benhur Amanuel
01 Jan 2014
Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
Siria A Lemma ... Taina Turpeenniemi‐Hujanen
European Journal of Haematology | VOL. 96
Siria A Lemma, et. al.Siria A Lemma ... Taina Turpeenniemi‐Hujanen
07 Aug 2015
View more papers

More From: Leukemia & lymphoma

Paper Title
Journal
Date
Author
Routine magnetic resonance central nervous system imaging may be avoided in high-risk systemic diffuse large B-cell lymphoma with negative cerebrospinal fluid analyses.
Rory Bennett ... Michael Dickinson
Leukemia & lymphoma | VOL. -
Rory Bennett, et. al.Rory Bennett ... Michael Dickinson
14 Jan 2025
Unusually indolent CML: a stable non-responder without complete cytogenetic remission for 30 years including 17 years on tyrosine kinase inhibitor therapy
Qiudan Shen ... Shimin Hu
Leukemia & Lymphoma | VOL. ahead-of-print
Qiudan Shen, et. al.Qiudan Shen ... Shimin Hu
11 Jan 2025
Effects of SCT genetic polymorphisms on methotrexate concentrations and toxicities in Chinese children with acute lymphoblastic leukemia
Miao Li ... Shu-Mei Wang
Leukemia & Lymphoma | VOL. ahead-of-print
Miao Li, et. al.Miao Li ... Shu-Mei Wang
11 Jan 2025
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD
Chiara Rusconi ... Paolo Corradini
Leukemia & Lymphoma | VOL. ahead-of-print
Chiara Rusconi, et. al.Chiara Rusconi ... Paolo Corradini
10 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.